Jara Rubio R, Martinez-Mellado AJ, Kiwitt-Cardenas J, Clavel JG, Garcia-Perez B, Castro P, Diaz-Ricart M, Carrillo-Alcaraz A, Lopez-Bernus A, Bernal Morell E, Roura A, Marin S, Ruiz-Lopez FJ, Solana-Martinez E, Martinez-Bano D, Albacete Moreno CL, Andreu Soler E, Tellez Santoyo A, Fernandez Mendez S, Noguera Velasco JA, Cebreiros Lopez I, Parrilla A, Espuny-Miro A, Garcia-Bernal D, Blanquer M, Sanchez-Salinas A, Iniesta F, Hernandez Garcia C, Muro M, Minguela Puras A, Moreno-Docon A, Torres-Cantero AM, Munoz Garcia M, Serrano M, Iacobelli M, Carlo-Stella C, Wei LJ, Richardson PG, Moraleda JM. Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19. Eur J Haematol. 2026 May 12. doi: 10.1111/ejh.70214. Online ahead of print. PubMed PMID: 42117493.
AÑO: 2026; IF: 2.3
